Beckman Drops Sequenom Suit

The suit alleged that Sequenom’s MassARRAY iPLEX products infringed three patents related to methods for determining nucleotide identity. A spokesperson for Beckman Coulter told IBO that no rulings or agreements were made by the court in the matter.

San Diego, CA 6/22/09; Washington, DC 6/25/09—The US District Court for the Southern District of California has dismissed Beckman Coulter and Orchid Cellmark’s patent infringement suit against Sequenom (see IBO 6/15/08), following the parties’ stipulation for dismissal. Sequenom stated that the patent infringement action was dismissed with prejudice, meaning it cannot be brought again, and that Beckman Coulter’s counterclaims were dismissed without prejudice. Sequenom also stated that it is not required to make any payments nor take a license. Both companies will pay for their own attorney fees.

< | >